Diasorin SpA (EUR)
DIA
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
IndustryDiagnostics & Research
Day Range96.80 | 99.80
52-Wk Range68.60 | 111.00
Last Close99.55
Mkt Cap (m)5,447.64
Dividend yield0.9%
ISINIT0003492391
Volume145,555
Exchange VenueMIL

Company Profile

Diasorin SpA is engaged in the development, manufacture and distribution ofimmunodiagnostics and molecular diagnostics tests.

Key Information
Price/Earning33.98
Price/Book7.29
Price/Sales7.96
P/CF25.58
Rev Growth (3 year avg)10.26
EPS Growth (3 year avg)0.16
Operating Margin % 31.36
Net Margin %23.63
Return on Equity21.87
Debt/Equity0.03

Legal Documents

Annual Report
en 31/12/2017

Financials

Income Statement
EUR201320142015201620172018
Revenue (m)435444499569637669
Operating Income (m)137132156178198210
Net Income (m)8384100112140158
Basic EPS1.531.551.832.052.542.85
Avg. Diluted Shares Outstanding (m)545455555556
Balance Sheet
EUR201320142015201620172018
Current Assets (m)318391494395482415
Non Current Assets (m)209215214473460491
Total Assets (m)527606708869946906
Current Liabilities (m)788282132141138
Total Liabilities (m)------
Total Equity (m)414483587663741705
Cash Flows
EUR201320142015201620172018
Operating Cash Flows (m)108120138166167210
Capital Expenditure (m)-32-31-32-37-42-53
Figures are quoted in EUR unless stated otherwise
-2.60 (-2.61%)
96.95
Last Price